Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026)
Iqvia Holdings (IQV) posted Cash from Financing Activities of -$214.0 million for Q2 2026, up 50.58% sequentially from -$433.0 million in Q1 2026, and down 247.59% YoY from $145.0 million in Q2 2025.
Iqvia Holdings (IQV) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Cash from Financing Activities for 15 years, with the latest figure at -$214.0 million in Q2 2026.
- Quarterly Cash from Financing Activities fell 247.59% year-over-year to -$214.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$684.0 million (down 9.44% YoY) and the FY2025 annual result came in at -$150.0 million, up 82.92% from the prior year.
- Cash from Financing Activities rose to -$214.0 million in Q2 2026 per IQV's latest filing, from -$433.0 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $535.0 million in Q4 2025 and troughed at -$572.0 million in Q3 2025.
- A 5-year average of -$132.6 million and a median of -$168.5 million in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 427.59% in 2023, then sank 373.68% in 2024.
- Over 5 years, Cash from Financing Activities stood at -$193.0 million in 2022, then tumbled by 117.62% to -$420.0 million in 2023, then rose by 10.71% to -$375.0 million in 2024, then soared by 242.67% to $535.0 million in 2025, then sank by 140.0% to -$214.0 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$214.0 million, -$433.0 million, and $535.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | -1.57 Bn |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | 7.27 Bn |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -325.19 Mn |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | -144.00 Mn |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -214.00 Mn |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 3.76 Mn |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -129.00 Mn |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -317.75 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | -229.00 Mn |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 580.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -214.00 Mn |
| Jun 30, 2026 | -214.00 Mn |
| Mar 31, 2026 | -433.00 Mn |
| Mar 31, 2026 | -433.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Dec 31, 2025 | 535.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Sep 30, 2025 | -572.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Mar 31, 2025 | -258.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Dec 31, 2024 | -375.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Sep 30, 2024 | -137.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Jun 30, 2024 | -260.00 Mn |
| Mar 31, 2024 | -106.00 Mn |
| Mar 31, 2024 | -106.00 Mn |